LOGIN
Platelet-Rich Plasma vs. Novel Cross-linked Hyaluronic Acid Injection for Early Knee Osteoarthritis
September 2022
Platelet-Rich Plasma vs. Novel Cross-linked Hyaluronic Acid Injection for Early Knee Osteoarthritis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparing the Efficacy of Intra-Articular Single Platelet-Rich Plasma(PRP) versus Novel Crosslinked Hyaluronic Acid for Early-Stage Knee Osteoarthritis: A Prospective, Double-Blind, Randomized Controlled Trial
Medicina (Kaunas). 2022 Aug 1;58(8): 1028.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
116 patients with early-stage knee osteoarthritis were randomized to receive a single intra-articular injection of a novel cross-linked hyaluronic acid (HA; n=58) or platelet-rich plasma (PRP; n=58). The outcome of interest was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and associated sub-scores, measured at 1, 3 and 6 months follow-up. Results revealed similar scor...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.